John Harlan
Neurology · Lees Summit, MONPI 1427086941
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 67.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2020 at $4,673 and has fallen 96.5% since, to $162 in 2025.
Across 155 payments — averaging $42.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Teva Pharmaceuticals USA, Inc.$291
- Supernus Pharmaceuticals, Inc.$222
- Amgen$187
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$162
- EMD Serono, Inc.$154
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$3,01246%
- Travel & lodging$62810%
- Food & beverage$2,89044%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $4,405 |
| Teva Pharmaceuticals USA, Inc. | 16 | $291 |
| Supernus Pharmaceuticals, Inc. | 15 | $222 |
| Amgen | 6 | $187 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $162 |
| EMD Serono, Inc. | 9 | $154 |
| Biohaven Pharmaceuticals, Inc. | 16 | $139 |
| Novartis | 6 | $126 |
| Acorda Therapeutics, Inc | 2 | $108 |
| Biogen | 5 | $94 |
| Lilly USA, LLC | 5 | $70 |
| Sanofi | 4 | $65 |
| MDD US Operations, LLC | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Adamas Pharmaceuticals, Inc. | 3 | $52 |
| Lundbeck LLC | 3 | $46 |
| Acadia Pharmaceuticals Inc | 3 | $42 |
| Upsher-smith Laboratories LLC | 2 | $38 |
| Boston Scientific | 3 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $36 |
| AstraZeneca | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Aprecia Pharmaceuticals, LLC | 1 | $15 |
| Promius Pharma LLC | 1 | $15 |
| SK Life Science, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| GE HealthCare | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,550 in reported general payments places this provider in the 75th percentile of 381 neurology providers in Missouri.
Other neurology in Lees Summit
- William RosenfeldChesterfield$2.1M
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Curtis SchreiberBolivar$882K
- Robert NaismithSaint Louis$677K
- Daniel MattsonBridgeton$451K
- Siddharth KaulBridgeton$387K
- Barbara GreenChesterfield$352K
- Steven KosaNorth Kansas City$323K
- Seth HepnerBridgeton$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.